ATH 0.00% 0.5¢ alterity therapeutics limited

Approved drugs with CNS demyelination side effect., page-9

  1. 1,560 Posts.
    lightbulb Created with Sketch. 2


    Sure. The drug regulators in the UK and Sweden were waiting for his latest piece of irrelevant ancient history to award marketing approval of PBT2 this afternoon.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.